Cytarabine (Cy), which can be specifically transported into cells via ENT1 as an analogue of the nucleoside cytosine [22, 35, 36], was selected as a guide for targeted choriocarcinoma therapy. The gene discussed is SLC29A1; the disease is choriocarcinoma.